Can IPRs be part of the COVID-19 solution, rather than the problem?
As the USTR’s Special 301 Review for 2021 starts, calls for the WTO to declare an IPR waiver on all COVID-19 related medical…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
USTR
Govt committed to use TRIPS to protect domestic pharma: Nirmala Sitharaman
The reiteration came via a written reply in the Lok Sabha Minister of State (Independent Charge) in the Ministry of Commerce…
India off USTR’s OCR hook … for now
2015 Special 301 Review to be next test of India's IP laws